Cision
Cision[edit | edit source]
Cision is a global public relations and earned media software company and services provider. It is known for its media monitoring, media list building, and press release distribution services. Cision's software is widely used by public relations professionals to manage their media relations and communications strategies.
History[edit | edit source]
Cision was founded in 1867 as "Observer," a Swedish company that provided media monitoring services. Over the years, it expanded its services and geographical reach, eventually becoming a leading provider of PR software and services. In 2007, Observer rebranded as Cision.
In 2014, Cision merged with Vocus, another PR software company, to form a larger entity under the Cision name. This merger allowed Cision to expand its capabilities and market presence. In 2017, Cision went public on the New York Stock Exchange under the ticker symbol "CISN."
Services[edit | edit source]
Cision offers a range of services designed to help public relations professionals manage their media outreach and communications efforts. These services include:
- Media Monitoring: Cision provides tools to track media coverage across various platforms, including print, online, and broadcast media. This allows PR professionals to measure the impact of their campaigns and monitor brand mentions.
- Media Database: Cision maintains a comprehensive database of media contacts, which PR professionals can use to build targeted media lists for their campaigns.
- Press Release Distribution: Cision offers press release distribution services that allow organizations to disseminate their news to a wide audience, including journalists, bloggers, and influencers.
- Analytics and Reporting: Cision's software includes analytics tools that help users measure the effectiveness of their PR efforts, track engagement, and generate reports.
Technology[edit | edit source]
Cision's platform is built on advanced technology that integrates various aspects of media relations and communications. The platform uses artificial intelligence and machine learning to enhance its media monitoring capabilities and provide insights into media trends and audience engagement.
Acquisitions[edit | edit source]
Cision has acquired several companies to enhance its offerings and expand its market reach. Notable acquisitions include:
- PR Newswire: Acquired in 2016, PR Newswire is a leading press release distribution service that expanded Cision's distribution capabilities.
- TrendKite: Acquired in 2019, TrendKite is a media monitoring and analytics company that enhanced Cision's analytics offerings.
Impact on Public Relations[edit | edit source]
Cision has significantly impacted the field of public relations by providing tools that streamline media relations and enhance the ability of PR professionals to measure the impact of their work. Its comprehensive platform allows for more efficient management of media outreach and provides valuable insights into media trends and audience engagement.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD